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Acute kidney injury (AKI) remains a commonly encoun-
tered medical problem, often ﬁ   nding its way to the 
intensive care unit (ICU). Treatment involves normalisa-
tion of the circulation, and, failing that, renal replacement 
therapy (RRT) of whatever type.
Th   e interesting paper by Ostermann and Chang 
describes the correlation between parameters at initia-
tion of RRT and outcome in critically ill patients who 
underwent RRT [1]. Although the study is retrospective, 
it is however multicentred and includes a large number of 
patients. ICU survivors (55.9%) were signiﬁ  cantly younger, 
and less sick with less pre-existing chronic illnesses. In a 
multivariate analysis, mechanical ventilation and asso-
ciated neurological failure on the day of RRT were the 
strongest independent risk factors for mortality, followed 
by hepatic, gastrointestinal and haematological failure, 
and pre-existing health problems. A higher serum pH 
was independently associated with a better outcome. A 
raised urea and a low creatinine concentration at 
initiation of RRT were independent risk factors for dying. 
Similar risk factors for death from AKI have been 
identiﬁ   ed in the past, albeit at a single centre and 
including fewer patients [2,3]. Moreover, the data share 
similarities with several subsequent scoring systems for 
AKI – namely, age, need for ventilation, oligo-anuria, 
liver dysfunction and acidosis [4,5].
What should be borne in mind is that the data analysed 
are somewhat old, and that over this period there have 
been several changes in the ICU practice for RRT: not 
least in the choice of replacement ﬂ  uid and the dosing of 
RRT. Bicarbonate-buﬀ  ered haemoﬁ  ltration was not des-
cribed until 1991 and was not commercially available 
until the late 1990s. In addition, dosing of RRT has 
gradually increased during the past decade, and it is likely 
in the present study that the dose may have been inade-
quate, particularly in the patients receiving continuous 
arteriovenous techniques. Using the current buﬀ  ering 
techniques and RRT dose, therefore, the observed eﬀ  ects 
on acid–base parameters may not be so marked.
In medicine, much like politics, one of the essential 
ingredients is timing; however, there is only a small 
evidence base regarding the time to initiate RRT in AKI 
[6]. In Ostermann and Chang’s study, mortality was 
signiﬁ  cantly lower when RRT was started before the AKI 
stage III creatinine criteria were fulﬁ  lled (serum creatinine 
≤354 μmol/l or a rise in serum creatinine by >300% from 
baseline), and also when RRT was started <3 days after 
ICU admission [1]. Although these ﬁ  ndings may suggest 
that early initiation of RRT is beneﬁ  cial, the retrospective 
design of this study does not allow deﬁ  nitive conclusions 
that may directly inﬂ  uence practice to be drawn. Only 
one randomised controlled trial has so far investigated 
whether the timing of RRT improves outcome in a mixed 
ICU population with AKI, and the results were 
inconclusive [7]. A recent systematic review identiﬁ  ed 23 
studies on the timing of RRT, including 10 studies more 
than 30 years ago, and a subse  quent meta-analysis 
suggested that early initiation of RRT may improve 
outcome [8]. Th  e methodological quality of the trials 
favouring early timing is poor, however, and the studies 
cannot be sensibly combined in a meta-analysis because 
of the heterogeneity in the deﬁ  nitions of timing, study 
populations and RRT techniques.
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© 2010 BioMed Central LtdSeveral important questions therefore remain when 
considering RRT for AKI – namely, when to start treat-
ment, how long to continue treatment and, to a degree, 
how much treatment to give. Th  e answers to these 
questions will probably involve not only renal criteria, 
but also the severity of other organ failure(s). Although 
we do need properly designed randomised controlled 
trials to answer these questions, the identiﬁ  cation of risk 
factors for death following AKI may help in the design of 
future studies as well as, perhaps, the use of biomarkers. 
Th  e con  ventional renal criteria (creatinine and diuresis) 
are a poor reﬂ   ection of AKI and do not diﬀ  erentiate 
between pre-renal failure and intrinsic renal damage. 
Early initiation of RRT in pre-renal failure is probably less 
impor    tant given that it is likely to recover after resusci-
tation of the circulation. If AKI is the result of cellular 
injury due to ischemia, reperfusion, inﬂ  am  mation  or 
oxidant stress, however, early initiation may mitigate 
further damage. Th   e use of biomarkers may prove helpful 
to detect AKI at an early stage, to diﬀ   er en tiate  pre-renal 
failure from AKI, and to decide when to start or stop RRT 
[9]. We shall have to wait and see.
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